drugset / Trial / NCT01444807
Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases
RandomizedSingle-groupDouble-blindTreatment
Summary
Evaluate the efficacy and tolerability of sorafenib in RCC patients underwent to metastasectomy
Timeline
- Start
- 2011-12
- Primary completion
- 2017-03
- Completion
- 2022-03
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sorafenib | Small molecule | 400 mg | — |